UmanDiagnostics AB

UmanDiagnostics specializes in the early detection of diseases of the brain. Our main focus is the
development of immunochemical tools for fast and accurate determination of neurological and traumatic injuries.

UmanDiagnostics has close collaboration with research groups at many departments at Umeå University and the company also collaborates with a number of Swedish and foreign biotech companies. Researchers at UmanDiagnostics have earlier been involved in the development of the diagnostic S-100 assay, indicated for monitoring traumatic brain injuries and patients with malignant melanomas. S-100 is today used worldwide for these conditions. Behind the company UmanDiagnostics stands InRo BioMedTek AB, Uminova Invest AB, Norrlandsfonden and Innovationsbron.

Kategorier: Diagnostics

Gå till UmanDiagnostics ABs hemsida